Predicting treatment eligibility for hepatitis B in low income regions: Can treatment scores without HBV DNA testing serve the purpose?

J Hepatol. 2018 Oct;69(4):765-766. doi: 10.1016/j.jhep.2018.06.002. Epub 2018 Jul 11.

Authors

Brian J McMahon¹, Geoffrey Dusheiko²

Affiliations

¹ Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK 99508, USA. Electronic address: bdm9@cdc.gov.
² Kings College Hospital and University College London Medical School, London, UK. Electronic address: g.dusheiko@ucl.ac.uk.

PMID: 30007507
DOI: 10.1016/j.jhep.2018.06.002

No abstract available

Publication types

Editorial
Comment

MeSH terms

Africa
DNA, Viral
Hepatitis B Surface Antigens
Hepatitis B e Antigens*
Hepatitis B virus / genetics
Hepatitis B*
Humans

Substances

DNA, Viral
Hepatitis B Surface Antigens
Hepatitis B e Antigens